Jpmorgan Chase & Co »

Carisma Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $903 921 0.98
2024-06-30 $1.4k 921 1.52
2024-03-31 $27k 12k 2.27
2023-12-31 $52k 18k 2.93
2023-09-30 $74k 18k 4.23
2023-06-30 $184k 21k 8.77
2023-03-31 $999 291 3.44